Novel Perivascular Macrophage Mechanism to Promote Glymphatic Aβ Clearance After Stroke

Chunyi Li1,2, Tiemei Li1, Mengyan Hu1

  • 1Department of Neurology, Mental and Neurological Disease Research Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China (C.L., T.L., M.H., X.K., X.S., S.W., D.L., S.S., H.H., X.D., Y.L., Z.L., W.C.).

Stroke
|May 20, 2025
PubMed
Abstract

Insights

Parenchymal border macrophages (PBMs) are crucial for clearing amyloid-beta (Aβ) after stroke. Supplementing with MANF improves glymphatic function and cognitive outcomes, offering a potential therapeutic strategy.

Area of Science:

  • Neuroscience
  • Immunology
  • Cerebrovascular Research

Background:

  • Parenchymal border macrophages (PBMs) are strategically located at the brain-periphery interface and influence substance entry into the central nervous system.
  • The specific role of PBMs in clearing amyloid-beta (Aβ) following a stroke has not been previously investigated.

Purpose of the Study:

  • To investigate the role of PBMs in post-stroke Aβ clearance and its impact on cognitive function.
  • To explore the potential therapeutic effects of mesencephalic astrocyte-derived neurotrophic factor (MANF) in mitigating stroke-induced impairments.

Main Methods:

  • Focal cerebral ischemia was induced in mice via middle cerebral artery occlusion.
  • PBMs were depleted using clodronate liposomes administered intrathecally prior to stroke induction.
  • Assessment included sensorimotor and cognitive functions, glymphatic system activity, and Aβ accumulation up to 34 days post-stroke.

Main Results:

  • Stroke led to Aβ accumulation in both hemispheres, with reduced glymphatic drainage and cognitive decline upon PBM depletion.
  • Mesencephalic astrocyte-derived neurotrophic factor (MANF) derived from PBMs was found to suppress astrocytic stress and maintain glymphatic drainage.
  • Downregulation of MANF in PBMs during the chronic stroke phase exacerbated glymphatic impairment, Aβ accumulation, and cognitive decline.

Conclusions:

  • PBMs play a critical role in post-stroke Aβ clearance and maintaining glymphatic function.
  • MANF supplementation demonstrated therapeutic potential by improving glymphatic system function and mitigating adverse effects of PBM depletion.
  • MANF represents a promising therapeutic strategy for preventing post-stroke cognitive impairment.